Study guide
3.1 Neonatal Blood Gas Interpretation & Acid-Base Balance
NCC Low Risk Neonatal Nursing RNC-LRN
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Overview & Maternal-Fetal Risk Assessment
1.1 RNC-LRN Exam Structure, Eligibility & Test Blueprint 1.2 Maternal Health Conditions & Prenatal Risk Factors 1.3 Intrapartum Events & Fetal Surveillance Interpretation 1.4 Antepartum Fetal Surveillance, Labor Progression & Perinatal Screening
2 Chapter 2: Comprehensive Neonatal Assessment & Gestational Age
2.1 Physical Assessment & Normal Variations vs. Abnormalities 2.2 Gestational Age Assessment: New Ballard Score & Maturity Classification 2.3 Neurobehavioral Assessment & Primitive Reflexes
3 Chapter 3: Neonatal Diagnostic & Laboratory Evaluation
3.1 Neonatal Blood Gas Interpretation & Acid-Base Balance 3.2 Hematologic & Metabolic Laboratory Diagnostics 3.3 Newborn Screening & Diagnostic Imaging Modalities
4 Chapter 4: Neonatal Respiratory Pathophysiology & Management
4.1 Respiratory Distress Syndrome (RDS) & Surfactant Deficiency 4.2 Transient Tachypnea of the Newborn (TTN) 4.3 Meconium Aspiration Syndrome (MAS) & Air Leaks 4.4 Apnea of Prematurity (AOP) & Persistent Pulmonary Hypertension (PPHN) 4.5 Oxygenation Assessment & Non-Invasive Respiratory Support
5 Chapter 5: Neonatal Cardiovascular Conditions & Hemodynamics
5.1 Fetal-to-Neonatal Circulatory Transition & Innocent Murmurs 5.2 Patent Ductus Arteriosus (PDA) & Ductal-Dependent Cardiac Lesions 5.3 Congenital Heart Defects & CCHD Pulse Oximetry Screening
6 Chapter 6: Neurologic & Gastrointestinal/Genitourinary Disorders
6.1 Hypoxic-Ischemic Encephalopathy (HIE) & Therapeutic Hypothermia 6.2 Neonatal Seizures & Intraventricular Hemorrhage (IVH) 6.3 Gastrointestinal Pathologies & Necrotizing Enterocolitis (NEC) 6.4 Congenital GI/GU Anomalies & Renal Function
7 Chapter 7: Hematology, Hyperbilirubinemia, and Genetic/Endocrine Conditions
7.1 Neonatal Hyperbilirubinemia & Kernicterus Risk 7.2 Hemolytic Disease & Neonatal Hematologic Disorders 7.3 Inborn Errors of Metabolism & Endocrine Disorders 7.4 Infant of a Diabetic Mother (IDM) & Chromosomal Anomalies
8 Chapter 8: Resuscitation & Immediate Neonatal Stabilization
8.1 Neonatal Resuscitation Program (NRP) 9th Edition Core Algorithm 8.2 Advanced Resuscitation: Chest Compressions & Emergency Medications 8.3 Post-Resuscitation Stabilization & The S.T.A.B.L.E. Framework
9 Chapter 9: Nutrition, Feeding & Gastrointestinal Support
9.1 Maternal Breast Milk, Lactation Support & Donor Milk 9.2 Nutritional Fortification & Specialized Formula Selection 9.3 Enteral Feeding Methods, Trophic Feeds & Gavage Administration
10 Chapter 10: Thermoregulation, Fluids, Electrolytes & Glucose Management
10.1 Thermoregulation & Prevention of Cold Stress 10.2 Fluid Requirements & Electrolyte Management 10.3 Neonatal Hypoglycemia Assessment & Management Protocols
11 Chapter 11: Infection Control, Sepsis & Neonatal Pharmacology
11.1 Early-Onset vs. Late-Onset Sepsis & Maternal GBS Management 11.2 Infection Prevention, CLABSI Bundles & Antimicrobial Stewardship 11.3 Neonatal Pharmacology & High-Alert Medication Administration 11.4 Congenital & Perinatal Infections, Sexually Transmitted Infections and Immune Function 11.5 Vitamin K, Eye Prophylaxis, Immunization & Routine Neonatal Medications
12 Chapter 12: Neurodevelopmental Care, Family-Centered Care & Discharge Transition
12.1 Developmental Care, Stress Reduction & Non-Pharmacologic Pain Management 12.2 Neonatal Abstinence Syndrome (NAS/NOWS) & Eat, Sleep, Console (ESC) 12.3 Discharge Readiness, Car Seat Challenge & Safe Sleep Education 12.4 Psychosocial Support, Family Adaptation & Perinatal Grief 12.5 Home Care Technology, Developmental Follow-Up & Community Referral
13 Chapter 13: Professional Issues, Safety, Quality & Ethics in Neonatal Nursing
13.1 Patient Safety, Error Prevention & Quality Improvement 13.2 Bioethics, Legal Standards & Family Advocacy
14 Chapter 14: Musculoskeletal, Integumentary & Birth Injury Conditions
14.1 Musculoskeletal Anomalies & Neonatal Birth Injuries 14.2 Neonatal Skin: Barrier Physiology, Normal Variations & Common Lesions
3.1 Neonatal Blood Gas Interpretation & Acid-Base Balance
Key Takeaways Explain This Topic AI
Arterial blood gas (ABG) is the gold standard for neonatal acid-base and oxygenation assessment, with normal post-transition (>24h) arterial reference values of pH 7.35-7.45, PaCO2 35-45 mmHg, PaO2 50-80 mmHg, HCO3 19-26 mEq/L, and Base Deficit/Excess -4 to +4 mEq/L.
Capillary blood gases (CBGs) from a properly warmed heel correlate accurately with arterial pH and PaCO2, but capillary PO2 is completely unreliable and must NEVER be used to assess hypoxemia, hyperoxemia, or titrate supplemental oxygen.
Respiratory alkalosis (PaCO2 <35 mmHg) causes cerebral vasoconstriction and marked reductions in cerebral blood flow, significantly increasing the risk of periventricular leukomalacia (PVL) and intraventricular hemorrhage in preterm and term neonates.
Metabolic acidosis is evaluated using the serum anion gap [Na - (Cl + HCO3)]; high anion gap (>16 mEq/L) reflects lactic acidosis, inborn errors of metabolism, or renal failure, and treatment prioritizes volume/perfusion restoration while restricting sodium bicarbonate due to IVH and paradoxical intracellular acidosis risks.
Oxygenation Index (OI = [Mean Airway Pressure x FiO2 x 100] / PaO2) quantifies the severity of hypoxemic respiratory failure: an OI >15 indicates moderate disease, OI >25 warrants inhaled nitric oxide (iNO), and OI >40 triggers consideration for Extracorporeal Membrane Oxygenation (ECMO).
Last updated: August 2026
3.1 Neonatal Blood Gas Interpretation & Acid-Base Balance
Acid-base balance and pulmonary gas exchange are fundamental physiological parameters monitored in both well newborns undergoing extrauterine transition and critically ill neonates in Level I and Level II neonatal units. Rapid, precise interpretation of blood gas measurements allows the neonatal nurse to identify respiratory insufficiency, circulatory compromise, metabolic derangements, and impending cardiopulmonary collapse.
1. Blood Gas Sampling Modalities & Reference Values
Blood gas analysis evaluates ventilation (removal of carbon dioxide, PCO 2 \text{PCO}_2 PCO 2 ), oxygenation (dissolved oxygen in arterial blood, PO 2 \text{PO}_2 PO 2 ), and systemic acid-base status ( pH \text{pH} pH , HCO 3 − \text{HCO}_3^- HCO 3 − , and Base Excess/Deficit). The clinical utility and physiological accuracy of each measurement depend heavily on the sampling site and collection technique.
Sampling Sites: Arterial vs. Capillary vs. Venous
Arterial Blood Gas (ABG):
Gold Standard: ABG provides the only accurate measurement of arterial oxygenation ( PaO 2 \text{PaO}_2 PaO 2 ) and is the definitive standard for assessing true alveolar ventilation ( PaCO 2 \text{PaCO}_2 PaCO 2 ) and systemic acid-base balance.
Sampling Sites: Indwelling umbilical arterial catheter (UAC), radial artery puncture, or posterior tibial artery puncture. (The brachial and femoral arteries should be avoided due to the risk of distal limb ischemia, median nerve injury, and avascular necrosis of the femoral head).
Pre-ductal vs. Post-ductal Sampling: Right radial artery blood is pre-ductal (originating from the brachiocephalic trunk proximal to the ductus arteriosus), reflecting oxygen delivery to the cerebral and coronary circulations. Post-ductal sites (left arm, lower extremities, UAC) reflect blood downstream of the ductal shunt, which may be significantly lower in the presence of right-to-left ductal shunting (e.g., in Persistent Pulmonary Hypertension of the Newborn [PPHN]).
Capillary Blood Gas (CBG):
Indications & Correlation: Utilized for serial monitoring of ventilation and acid-base status when arterial access is unavailable. Capillary pH \text{pH} pH and PCO 2 \text{PCO}_2 PCO 2 correlate well with arterial values ( r > 0.90 r > 0.90 r > 0.90 ) provided the sampling site is properly arterialized.
Critical Limitation — PO 2 \text{PO}_2 PO 2 Inaccuracy: Capillary PO 2 \text{PO}_2 PO 2 reflects local capillary-tissue bed extraction and bears no reliable correlation with PaO 2 \text{PaO}_2 PaO 2 . CBG must never be used to assess hypoxemia, rule out hyperoxemia, or titrate fractional inspired oxygen ( FiO 2 \text{FiO}_2 FiO 2 ) in neonates receiving oxygen therapy (due to the risk of retinopathy of prematurity in preterm infants).
Arterialization Technique: The lateral or medial plantar border of the heel is warmed to 40 ∘ C − 42 ∘ C 40^{\circ}\text{C}-42^{\circ}\text{C} 4 0 ∘ C − 4 2 ∘ C for 3 to 5 minutes to induce local arteriolar vasodilation. Excessive squeezing, milking, or sampling from a cold, edematous, or poorly perfused extremity introduces interstitial fluid and venous stasis, resulting in falsely low pH \text{pH} pH , falsely high PCO 2 \text{PCO}_2 PCO 2 , and spuriously elevated lactate.
Venous Blood Gas (VBG):
Clinical Utility: Useful for evaluating systemic acid-base balance ( pH \text{pH} pH and HCO 3 − \text{HCO}_3^- HCO 3 − ), particularly during initial resuscitation, screening for sepsis, or metabolic emergencies.
Correlation: Venous pH \text{pH} pH is typically 0.03 − 0.05 0.03-0.05 0.03 − 0.05 lower than arterial pH \text{pH} pH , and PvCO 2 \text{PvCO}_2 PvCO 2 is 4 − 6 mmHg 4-6\text{ mmHg} 4 − 6 mmHg higher due to cellular metabolic waste addition. Venous PO 2 \text{PO}_2 PO 2 reflects tissue oxygen extraction (normal venous PvO 2 \text{PvO}_2 PvO 2 30 − 40 mmHg 30-40\text{ mmHg} 30 − 40 mmHg ) and cannot be used to assess pulmonary gas exchange or arterial oxygenation.
Neonatal Blood Gas Reference Ranges Across Postnatal Adaptation
Parameter Arterial (First 24 Hours) Arterial (> 24 Hours / Stable) Capillary (Warmed Heel) Venous (Peripheral/Central)
pH 7.30 − 7.45 7.30 - 7.45 7.30 − 7.45 7.35 − 7.45 7.35 - 7.45 7.35 − 7.45 7.30 − 7.40 7.30 - 7.40 7.30 − 7.40 7.30 − 7.38 7.30 - 7.38 7.30 − 7.38
PCO 2 \text{PCO}_2 PCO 2 (mmHg) 35 − 50 35 - 50 35 − 50 35 − 45 35 - 45 35 − 45 38 − 50 38 - 50 38 − 50 40 − 52 40 - 52 40 − 52
PO 2 \text{PO}_2 PO 2 (mmHg) 50 − 70 50 - 70 50 − 70 (term: 60 − 80 60-80 60 − 80 ) 50 − 80 50 - 80 50 − 80 (preterm: 50 − 70 50-70 50 − 70 ) 35 − 45 35 - 45 35 − 45 (Unreliable for oxygenation) 30 − 40 30 - 40 30 − 40
HCO 3 − \text{HCO}_3^- HCO 3 − (mEq/L) 19 − 24 19 - 24 19 − 24 20 − 26 20 - 26 20 − 26 (preterm: 18 − 22 18-22 18 − 22 ) 19 − 24 19 - 24 19 − 24 20 − 26 20 - 26 20 − 26
Base Deficit / Excess − 4 to + 4 mEq/L -4\text{ to }+4\text{ mEq/L} − 4 to + 4 mEq/L − 4 to + 2 mEq/L -4\text{ to }+2\text{ mEq/L} − 4 to + 2 mEq/L − 4 to + 4 mEq/L -4\text{ to }+4\text{ mEq/L} − 4 to + 4 mEq/L − 4 to + 4 mEq/L -4\text{ to }+4\text{ mEq/L} − 4 to + 4 mEq/L
SaO 2 \text{SaO}_2 SaO 2 / SpO 2 \text{SpO}_2 SpO 2 90 % − 97 % 90\% - 97\% 90% − 97% 92 % − 98 % 92\% - 98\% 92% − 98% (preterm: 90 − 95 % 90-95\% 90 − 95% ) N/A 65 % − 75 % 65\% - 75\% 65% − 75%
Clinical Pearl — Physiological Acidosis of Birth: Immediately after delivery, healthy cord blood demonstrates a mild physiological mixed acidosis (umbilical artery pH ≥ 7.20 − 7.25 \text{pH} \ge 7.20-7.25 pH ≥ 7.20 − 7.25 , PCO 2 ≤ 55 mmHg \text{PCO}_2 \le 55\text{ mmHg} PCO 2 ≤ 55 mmHg , Base Deficit ≤ 8 mEq/L \le 8\text{ mEq/L} ≤ 8 mEq/L ). Healthy neonates rapidly clear accumulated carbon dioxide and lactate through spontaneous respirations and non-shivering thermogenesis, normalizing their blood gas within 1 to 2 hours of life.
Loading diagram... Systematic Neonatal Blood Gas & Acid-Base Diagnostic Flowchart
2. Primary Acid-Base Disturbances in the Neonate
Acid-base derangements in the neonate fall into four classic categories. Understanding the underlying pathophysiology, compensatory mechanisms, and specific nursing interventions is critical for board certification.
1. Respiratory Acidosis
Definition: pH < 7.35 \text{pH} < 7.35 pH < 7.35 with an elevated PaCO 2 > 45 − 50 mmHg \text{PaCO}_2 > 45-50\text{ mmHg} PaCO 2 > 45 − 50 mmHg .
Pathophysiology: Caused by alveolar hypoventilation leading to retention of carbon dioxide. In water, dissolved CO 2 \text{CO}_2 CO 2 combines with H 2 O \text{H}_2\text{O} H 2 O via carbonic anhydrase to form carbonic acid ( H 2 CO 3 \text{H}_2\text{CO}_3 H 2 CO 3 ), which dissociates into H + \text{H}^+ H + and HCO 3 − \text{HCO}_3^- HCO 3 − .
Common Neonatal Etiologies:
Pulmonary parenchymal disease: Respiratory Distress Syndrome (RDS due to surfactant deficiency), Transient Tachypnea of the Newborn (TTN), Meconium Aspiration Syndrome (MAS), pneumonia, pulmonary hemorrhage.
Airway obstruction: Laryngomalacia, choanal atresia, subglottic stenosis, mucus plugging, malpositioned endotracheal tube (right mainstem intubation).
Thoracic / Neuromuscular: Pneumothorax, diaphragmatic hernia, severe abdominal distension compressing the diaphragm, central nervous system depression from maternal opioids or hypoxic-ischemic encephalopathy (HIE).
Physiological Compensation: Renal retention of bicarbonate and increased excretion of hydrogen ions (titratable acid and ammonium). Renal compensation is slow, requiring 24 to 48 hours to achieve full effect. In acute respiratory acidosis, bicarbonate rises only ∼ 1 mEq/L \sim 1\text{ mEq/L} ∼ 1 mEq/L for every 10 mmHg 10\text{ mmHg} 10 mmHg rise in PaCO 2 \text{PaCO}_2 PaCO 2 .
Clinical Signs: Tachypnea with retractions, nasal flaring, grunting, lethargy, cyanosis, and tachycardia.
Nursing & Collaborative Interventions:
Optimize airway patency: gentle suctioning of secretions, repositioning neck into a neutral "sniffing" position.
Non-invasive respiratory support: initiate or increase Continuous Positive Airway Pressure (CPAP) or PEEP to restore functional residual capacity (FRC) and prevent alveolar atelectasis.
Mechanical ventilation adjustments: increase minute ventilation by increasing ventilator rate or increasing inspiratory pressure/tidal volume ( PIP \text{PIP} PIP or Vt \text{Vt} Vt ).
2. Respiratory Alkalosis
Definition: pH > 7.45 \text{pH} > 7.45 pH > 7.45 with a decreased PaCO 2 < 35 mmHg \text{PaCO}_2 < 35\text{ mmHg} PaCO 2 < 35 mmHg .
Pathophysiology: Alveolar hyperventilation blowing off carbon dioxide faster than it is produced metabolically.
Common Neonatal Etiologies:
Iatrogenic over-ventilation: Excessive mandatory rate or excessive tidal volume delivery on mechanical ventilators.
Central nervous system irritation: Neonatal encephalopathy, intracranial hemorrhage, meningitis, pain, or maternal drug withdrawal (Neonatal Abstinence Syndrome / NOWS).
Early compensatory response: Early stages of mild hypoxemia or fever.
Severe Neurological Risk — Hypocapnia & Periventricular Leukomalacia (PVL):
Carbon dioxide is the primary physiological regulator of cerebral arteriolar tone. A rapid or sustained drop in PaCO 2 < 30 − 35 mmHg \text{PaCO}_2 < 30-35\text{ mmHg} PaCO 2 < 30 − 35 mmHg causes severe cerebral vasoconstriction and decreases cerebral blood flow by up to 30 − 50 % 30-50\% 30 − 50% .
Hypocapnia shifts the oxyhemoglobin dissociation curve to the left (Bohr effect), impairing oxygen unloading to brain tissue. In preterm infants, iatrogenic hypocapnia is strongly linked to ischemic cerebral white matter necrosis ( cystic PVL ) and neurodevelopmental impairment (spastic diplegia cerebral palsy).
Nursing Interventions:
Immediately decrease ventilator rate or decrease peak inspiratory pressure / tidal volume.
If patient is spontaneously hyperventilating on synchronous modes, adjust pressure support or assess for pain, agitation, and hyperthermia.
3. Metabolic Acidosis
Definition: pH < 7.35 \text{pH} < 7.35 pH < 7.35 with a decreased HCO 3 − < 19 mEq/L \text{HCO}_3^- < 19\text{ mEq/L} HCO 3 − < 19 mEq/L and a negative Base Excess (Base Deficit) < − 4 mEq/L < -4\text{ mEq/L} < − 4 mEq/L .
Pathophysiology: Accumulation of non-volatile organic acids, inability of the kidneys to excrete fixed acids, or excessive loss of bicarbonate from the gastrointestinal or renal systems.
The Serum Anion Gap: Anion Gap = [ Na + ] − ( [ Cl − ] + [ HCO 3 − ] ) \text{Anion Gap} = [\text{Na}^+] - ([\text{Cl}^-] + [\text{HCO}_3^-]) Anion Gap = [ Na + ] − ([ Cl − ] + [ HCO 3 − ])
Normal Neonatal Anion Gap: 8 − 16 mEq/L 8 - 16\text{ mEq/L} 8 − 16 mEq/L (values up to 18 mEq/L 18\text{ mEq/L} 18 mEq/L may be normal in the first 48 hours of life).
High Anion Gap Acidosis ( > 16 mEq/L > 16\text{ mEq/L} > 16 mEq/L ): Indicates accumulation of unmeasured anions (organic acids). Primary etiologies include:
Lactic acidosis: Severe tissue hypoxemia, cardiogenic shock, septic shock, hypovolemia, cold stress, necrotizing enterocolitis (NEC), severe anemia, or patent ductus arteriosus (PDA) steal.
Inborn Errors of Metabolism (IEM): Organic acidemias (methylmalonic, propionic, isovaleric acidemias), Maple Syrup Urine Disease (MSUD), fatty acid oxidation defects.
Acute Kidney Injury (AKI): Uremic toxins, phosphates, sulfates.
Normal Anion Gap (Hyperchloremic) Acidosis ( 8 − 16 mEq/L 8 - 16\text{ mEq/L} 8 − 16 mEq/L ): Direct loss of bicarbonate with reciprocal chloride retention:
Gastrointestinal base loss: Severe diarrhea, ileostomy drainage, proximal enterostomy.
Renal base loss: Renal tubular acidosis (proximal Type II or distal Type I), immature preterm renal tubular bicarbonate reabsorption.
Excessive administration of 0.9 % NaCl 0.9\%\text{ NaCl} 0.9% NaCl ("saline-induced hyperchloremic acidosis").
Management & Sodium Bicarbonate Warnings:
Treat the underlying cause: The primary therapy is restoring tissue perfusion and oxygen delivery by administering an isotonic crystalloid fluid bolus ( 10 mL/kg 10\text{ mL/kg} 10 mL/kg of 0.9 % NaCl 0.9\%\text{ NaCl} 0.9% NaCl over 30-60 minutes) for hypovolemia, providing inotropic support for cardiogenic shock, rewarming a cold-stressed infant, and initiating broad-spectrum antibiotics for sepsis.
Sodium Bicarbonate ( NaHCO 3 \text{NaHCO}_3 NaHCO 3 ) Hazards: Routine or rapid sodium bicarbonate administration is contraindicated . When NaHCO 3 \text{NaHCO}_3 NaHCO 3 combines with H + \text{H}^+ H + , it generates CO 2 \text{CO}_2 CO 2 and H 2 O \text{H}_2\text{O} H 2 O . If alveolar ventilation cannot instantly excrete this excess CO 2 \text{CO}_2 CO 2 , the lipophilic CO 2 \text{CO}_2 CO 2 crosses cell membranes and the blood-brain barrier much faster than bicarbonate, causing paradoxical intracellular and cerebral CNS acidosis . Furthermore, hyperosmolar NaHCO 3 \text{NaHCO}_3 NaHCO 3 ( 4.2 % 4.2\% 4.2% or 8.4 % 8.4\% 8.4% ) causes rapid plasma volume shifts, drastically increasing the incidence of intraventricular hemorrhage (IVH) in preterm infants.
If prescribed for documented refractory metabolic acidosis during prolonged resuscitation, NaHCO 3 \text{NaHCO}_3 NaHCO 3 must be diluted 1 : 1 1:1 1 : 1 with sterile water (making a 0.5 mEq/mL 0.5\text{ mEq/mL} 0.5 mEq/mL 4.2 % 4.2\% 4.2% solution) and infused very slowly over at least 20 to 30 minutes with verified adequate mechanical ventilation.
4. Metabolic Alkalosis
Definition: pH > 7.45 \text{pH} > 7.45 pH > 7.45 with an elevated HCO 3 − > 26 mEq/L \text{HCO}_3^- > 26\text{ mEq/L} HCO 3 − > 26 mEq/L and a positive Base Excess > + 4 mEq/L > +4\text{ mEq/L} > + 4 mEq/L .
Pathophysiology & Causes:
Loss of hydrochloric acid from continuous nasogastric or orogastric suctioning, or persistent non-bilious projectile vomiting in infantile hypertrophic pyloric stenosis.
Chronic loop diuretic therapy (e.g., furosemide / Lasix in bronchopulmonary dysplasia), causing massive renal excretion of chloride, sodium, and potassium, resulting in hypochloremic, hypokalemic metabolic alkalosis.
Iatrogenic over-administration of acetate in parenteral nutrition or excessive sodium bicarbonate infusions.
Management: Discontinue or reduce diuretic dosing; replace gastric aspirates with 0.45 % 0.45\% 0.45% or 0.9 % NaCl 0.9\%\text{ NaCl} 0.9% NaCl ; administer potassium chloride ( KCl \text{KCl} KCl ) to correct potassium deficits.
- 3. Mixed Acid-Base Disturbances & Oxygenation Indices
- Mixed Acid-Base Disorders
In complex clinical scenarios, two primary acid-base derangements occur simultaneously:
Combined Respiratory and Metabolic Acidosis: The most common life-threatening emergency in neonatology. Seen in severe perinatal depression/asphyxia, meconium aspiration syndrome with cardiorespiratory collapse, and septic shock with pulmonary edema. The blood gas exhibits profound acidemia ( pH < 7.00 − 7.15 \text{pH} < 7.00-7.15 pH < 7.00 − 7.15 ), severe hypercapnia ( PaCO 2 > 65 − 80 mmHg \text{PaCO}_2 > 65-80\text{ mmHg} PaCO 2 > 65 − 80 mmHg ), low bicarbonate ( HCO 3 − < 14 − 16 mEq/L \text{HCO}_3^- < 14-16\text{ mEq/L} HCO 3 − < 14 − 16 mEq/L ), and a massive base deficit ( < − 15 to − 20 mEq/L < -15\text{ to }-20\text{ mEq/L} < − 15 to − 20 mEq/L ).
Quantifying Oxygenation Failure: P/F Ratio & Oxygenation Index (OI)
PaO 2 / FiO 2 \text{PaO}_2 / \text{FiO}_2 PaO 2 / FiO 2 (P/F) Ratio:
Calculates arterial oxygen tension relative to inspired oxygen fraction ( 0.21 − 1.0 0.21 - 1.0 0.21 − 1.0 ).
Normal: > 400 − 500 mmHg > 400 - 500\text{ mmHg} > 400 − 500 mmHg .
Mild hypoxemic failure: 200 − 300 mmHg 200 - 300\text{ mmHg} 200 − 300 mmHg ; Moderate: 100 − 200 mmHg 100 - 200\text{ mmHg} 100 − 200 mmHg ; Severe: < 100 mmHg < 100\text{ mmHg} < 100 mmHg .
Oxygenation Index (OI): The Oxygenation Index is the premier clinical metric utilized in neonatal intensive care to quantify the severity of hypoxemic respiratory failure and pulmonary hypertension by incorporating the mean airway pressure ( MAP \text{MAP} MAP or Paw \text{Paw} Paw , in cmH 2 O \text{cmH}_2\text{O} cmH 2 O ) required to achieve oxygenation. OI = Mean Airway Pressure (MAP, cmH 2 O) × FiO 2 ( % ) × 100 PaO 2 ( mmHg ) \text{OI} = \frac{\text{Mean Airway Pressure (MAP, }\text{cmH}_2\text{O)} \times \text{FiO}_2 (\%) \times 100}{\text{PaO}_2 (\text{mmHg})} OI = PaO 2 ( mmHg ) Mean Airway Pressure (MAP, cmH 2 O) × FiO 2 ( % ) × 100
(Where FiO 2 \text{FiO}_2 FiO 2 is expressed as a fraction 0.21 − 1.0 0.21-1.0 0.21 − 1.0 , or MAP × FiO 2 [%] PaO 2 \frac{\text{MAP} \times \text{FiO}_2\text{ [\%]} }{\text{PaO}_2} PaO 2 MAP × FiO 2 [%] )
Oxygenation Index (OI) Clinical Interpretation Collaborative Interventions
OI < 15 Mild or resolving parenchymal lung disease Maintain standard mechanical ventilation; wean FiO 2 \text{FiO}_2 FiO 2 and pressures as tolerated
OI 15 – 25 Moderate hypoxemic respiratory failure Optimize lung recruitment (High-Frequency Oscillatory Ventilation [HFOV] or Jet ventilation), perform echocardiogram to assess pulmonary pressures and cardiac anatomy
OI > 25 Severe hypoxemic respiratory failure / PPHN Initiate Inhaled Nitric Oxide (iNO) at 20 ppm 20\text{ ppm} 20 ppm ; optimize sedation and muscle relaxation if indicated
OI > 40 Critical, refractory hypoxemic respiratory failure Evaluate for Extracorporeal Membrane Oxygenation (ECMO) consultation and transfer to an ECMO center